Kirkland Signature Smoked Salmon products recalled in October 2024 are now considered to be a Class 1 recall, the FDA’s most ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

An investigational, novel combination therapy, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized relapse prevention ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

President Donald Trump’s pick for secretary of agriculture -- was asked about tariffs, bird flu, the effect of mass ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...